• p-Tau Ser356, NUAK Inhibition, and Alzheimer’s

  2026-08-30

  Taylor et al. show that tau phosphorylated at Ser356 increases with Alzheimer’s disease stage, is frequently present in neurofibrillary tangles, and localizes near synapses in postmortem tissue. Their ex vivo experiments further demonstrate that NUAK inhibition produces distinct mouse and human brain-slice responses, emphasizing the need to interpret target engagement alongside neuronal and synaptic integrity.

• Calpain Inhibitor II (ALLM) for Protease Workflows

  2026-08-29

  Calpain Inhibitor II, ALLM enables cell-based and biochemical interrogation of calpain- and cathepsin-linked proteolysis. This guide translates the FAISL–calpain 2–FAK mechanism in triple-negative breast cancer into practical apoptosis, focal-adhesion, and protease inhibition workflows while emphasizing controls for its multi-protease activity.

• Berberrubine Targets IMPDH2 in Colorectal Cancer

  2026-08-28

  The 2023 Biochemical Pharmacology study identifies berberrubine as a selective, competitive inhibitor of IMPDH2, links elevated IMPDH2 to poor colorectal cancer prognosis, and validates growth suppression in cell and mouse models. Its guanosine-rescue experiments and dual in vivo design provide a useful framework for mechanism-led colorectal cancer research, while salt form, exposure, selectivity, and clinical translation remain open questions.

• BMN 673: PARP Trapping Meets Splicing Biology

  2026-08-28

  BMN 673 (Talazoparib) provides a powerful way to study PARP trapping in DNA repair-deficient models. This article connects its pharmacology with spliceosome-controlled homologous recombination phenotypes and translates that insight into practical assay decisions.

• WST-8 Glucose Uptake Assay Kit Workflow

  2026-08-27

  Turn 2-deoxyglucose transport into a fast, non-radioactive readout for cancer metabolism, diabetes research, and delivery studies. This workflow shows how to pair the WST-8 Glucose Uptake Assay Kit with controlled ion and nanoparticle experiments while avoiding common redox, cell-density, and matrix-related artifacts.

• REC8 Stabilizes MAVS and STING in Antiviral Immunity

  2026-08-27

  The reference study identifies REC8, traditionally associated with meiosis, as a positive regulator of antiviral innate immunity. It shows that SUMOylated REC8 relocates to the cytoplasm during infection, stabilizes MAVS and STING by limiting RNF5-driven K48-linked ubiquitination, and promotes TBK1 recruitment and interferon signaling.

• Salvianolic Acid B: Readouts That Matter

  2026-08-26

  Salvianolic acid B, also called Dan Shen Suan B, links LH2-associated collagen remodeling with pulmonary fibrosis assay design. This guide presents a causal, orthogonal framework for distinguishing reduced collagen deposition from genuine changes in matrix biology.

• RIP3 Stoichiometry Tunes Necrosome Signaling

  2026-08-26

  The reference study combines quantitative STORM imaging with mathematical modeling to show that necrosomes use an approximately 3:1 RIP3:RIP1 ratio to balance signal amplification with attenuation during necroptosis. Its finding that excessive RIP3 oligomerization suppresses signaling provides a mechanistic explanation for threshold behavior and offers a framework for interpreting higher-order signalosome regulation.

• Naloxone Hydrochloride: Receptor Blockade to Translation

  2026-08-25

  Naloxone hydrochloride is more than a standard opioid receptor antagonist. Its value as a translational research tool spans receptor signaling, withdrawal-associated behavior, neural stem cell proliferation modulation, and assay quality control. This article connects mechanistic evidence with practical study design and product-selection guidance.

• DiscoveryProbe Protease Inhibitor Library in HCC

  2026-08-25

  The DiscoveryProbe Protease Inhibitor Library converts broad protease biology into an automation-ready screening workflow for biochemical, cellular, and high-content assays. Its chemical diversity is especially useful for separating protease activity modulation from downstream effects in apoptosis and hepatocellular carcinoma research.

• Ac-YVAD-CMK Workflow for Caspase-1 Studies

  2026-08-24

  Ac-YVAD-CMK helps distinguish caspase-1-dependent cytokine maturation from upstream membrane injury in infection and pyroptosis models. This practical workflow translates Kupffer cell and TMEM16F findings into controlled assays for IL-1β, IL-18, cell death, and inflammatory signaling.

• Esculin Mechanisms in Renal Cell Carcinoma

  2026-08-24

  A 2024 Biomolecules study combines network pharmacology, molecular docking, and cell-based validation to examine how esculin may suppress renal cell carcinoma. The findings associate esculin with reduced proliferation and migration, increased cell death, and GAPDH-linked modulation of PI3K/Akt signaling, while remaining preliminary because the evidence is computational and in vitro.

• Chenodeoxycholic Acid: Reliable FXR Assays

  2026-08-23

  Learn how Chenodeoxycholic Acid (SKU B1908) can support reproducible FXR, viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers solubility, vehicle controls, protocol design, mechanistic interpretation, and practical vendor selection.

• CCT007093: From PPM1D to p38 Signal Logic

  2026-08-22

  Explore how CCT007093, a PPM1D inhibitor, converts phosphatase control into measurable p38 signaling and cell-death phenotypes. This article emphasizes causal assay design across breast cancer and kidney-injury models rather than repeating a conventional workflow.

• Nigericin Sodium Salt in Cancer Drug Assays

  2026-08-22

  Use Nigericin sodium salt as a controlled potassium ionophore to probe how ion gradients and cytoplasmic pH influence cell-state measurements. A workflow that pairs this perturbation with separate proliferation and cell-killing readouts can reveal drug-response differences hidden by a single viability endpoint.

3652 records 1/244 page Next 12345 下5页 Last page